UBC Scientists Present at ISPOR’s 18th Annual European Congress in Milan

UBC Scientists Present at ISPOR’s 18th Annual  European Congress in Milan

UBC Scientists Present at ISPOR’s 18th Annual European Congress in Milan

Health economists from across the globe gathered last week in Milan for ISPOR’s 18th Annual European Congress.  Attendees shared their research on the roles of outcomes assessment in decision making – covering new trends and challenges in today’s evolving healthcare landscape.

UBC scientists were pleased to present their research on a variety of health outcomes topics. If you missed them on-site, we’ve shared six accepted abstracts in our library:

Methodological Considerations for the Implementation of a European Mandated Retrospective Drug Utilisation Study (DUS) to Investigate the Use of Dexmedetomidine (Dexdor®) in Clinical Practice

Increasing Precision of Real-World Data Estimates: The Importance of a Step-Wise Process to Limit Data Collection Errors and Data Incompleteness

One-Year Cost-Comparison Analysis of Absorb™ Everolimus Eluting Bioresorbable Vascular Scaffold and Xience™ Everolimus Eluting Stent: Based on Findings From Absorb II

Results from a Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease from Italian Sites

A Time And Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease from Belgium

Cost of Paediatric Vaccine Administration in the United Kingdom (UK): A Time and Motion (T&M) Study

Our team of experts is available to discuss how our tailored real-world evidence generation solutions can help you demonstrate your product’s value to regulatory agencies, payers and pharmacists,  expediting approval and commercialization efforts. Please feel free to contact us if you’d like to learn more about these solutions.